EG. 5 (Eris) and BA. 2.86 (Pirola) two new subvariants of SARS-CoV-2: a new face of old COVID-19
Abstract Background The World Health Organization announced the end of the Coronavirus
Disease of 2019 (COVID-19) global health emergency on May 5, 2023. However, the reports …
Disease of 2019 (COVID-19) global health emergency on May 5, 2023. However, the reports …
Cholesterol and COVID-19—therapeutic opportunities at the host/virus interface during cell entry
T Grewal, MKL Nguyen, C Buechler - Life Science Alliance, 2024 - life-science-alliance.org
The rapid development of vaccines to combat severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infections has been critical to reduce the severity of COVID-19 …
coronavirus 2 (SARS-CoV-2) infections has been critical to reduce the severity of COVID-19 …
[HTML][HTML] The cGAS-STING pathway in cardiovascular diseases: from basic research to clinical perspectives
C An, Z Li, Y Chen, S Huang, F Yang, Y Hu, T Xu… - Cell & Bioscience, 2024 - Springer
The cyclic guanosine monophosphate (GMP)-adenosine monophosphate (AMP) synthase-
stimulator of interferon genes (cGAS-STING) signaling pathway, an important component of …
stimulator of interferon genes (cGAS-STING) signaling pathway, an important component of …
[HTML][HTML] Treg-derived TGF-β1 dampens cGAS-STING signaling to downregulate the expression of class I MHC complex in multiple myeloma
D Zhang, D Zhan, R Zhang, Y Sun, C Duan, J Yang… - Scientific Reports, 2024 - nature.com
Multiple myeloma (MM) progression involves diminished tumor antigen presentation and an
immunosuppressive microenvironment, characterized by diminished expression of major …
immunosuppressive microenvironment, characterized by diminished expression of major …